Prostate cancer metastatic and Prostatic specific antigen abnormal

Summary:

Prostatic specific antigen abnormal is found among people with Prostate cancer metastatic, especially for people who are 60+ old.

The study analyzes which people have Prostatic specific antigen abnormal with Prostate cancer metastatic. It is created by eHealthMe based on reports of 70 people who have Prostate cancer metastatic from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Prostate cancer metastatic?

Prostate cancer metastatic is found to be associated with 408 drugs and 339 conditions by eHealthMe. Check the latest studies of Prostate cancer metastatic.

What is Prostatic specific antigen abnormal?

Prostatic specific antigen abnormal is found to be associated with 92 drugs and 133 conditions by eHealthMe. Check the latest studies of Prostatic specific antigen abnormal.

On Jul, 18, 2026

70 people who have Prostate Cancer Metastatic and Prostatic Specific Antigen Abnormal are studied.

Would you have Prostatic specific antigen abnormal when you have Prostate cancer metastatic?

Age of people who have Prostate Cancer Metastatic and experienced Prostatic Specific Antigen Abnormal *:

Common co-existing conditions for these people *:

Prostate Cancer: 14 people, 20.00%
Osteoporosis (bones weak and more likely to break): 6 people, 8.57%
White Blood Cell Count Abnormal: 1 person, 1.43%
Stress And Anxiety: 1 person, 1.43%
Seasonal Allergy (allergic condition due to certain season): 1 person, 1.43%
Metastases To Bone (cancer spreads to bone): 1 person, 1.43%
Hypocholesterolaemia (presence of abnormally small amounts of cholesterol in the circulating blood): 1 person, 1.43%
Hypersensitivity: 1 person, 1.43%
High Blood Pressure: 1 person, 1.43%
High Blood Cholesterol: 1 person, 1.43%

Common drugs taken by these people *:

Common symptoms for these people *:

Fatigue (feeling of tiredness): 26 people, 37.14%
Metastases To Bone (cancer spreads to bone): 12 people, 17.14%
Blood Testosterone Abnormal: 10 people, 14.29%
Prostatic Specific Antigen Increased: 9 people, 12.86%
Weakness: 9 people, 12.86%
Seasonal Allergy (allergic condition due to certain season): 8 people, 11.43%
Hot Flush (sudden feelings of heat): 8 people, 11.43%
Fall: 8 people, 11.43%
Nasopharyngitis (inflammation of the nasopharynx): 8 people, 11.43%
Urinary Retention (the inability to completely or partially empty the bladder): 8 people, 11.43%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Prostatic specific antigen abnormal?

- Check whether Prostatic specific antigen abnormal is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Prostate cancer metastatic (23,132 reports)
Prostatic specific antigen abnormal (1,188 reports)

All the drugs that are associated with Prostatic specific antigen abnormal:

Prostatic specific antigen abnormal (92 drugs)

All the conditions that are associated with Prostatic specific antigen abnormal:

Prostatic specific antigen abnormal (133 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Prostatic specific antigen abnormal and Prostate cancer metastatic, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.